Fundación MEDINA

Our mission on drug discovery and pharma research

  • Home
  • About
    • Mission and Vision
    • Origins
    • Team
    • The Foundation
    • Governing board
    • Education & Training
    • Complaints channel
  • Research
    • Research at MEDINA
    • Research in Natural Products
    • Therapeutic Areas
    • Core Scientific Facilities
    • Collaboration & Partners
    • Scientific Publications
  • Services
    • Natural Products
    • Microbiology Services
    • Chemistry Services
      • Natural Products Chemistry
      • Mass Spectrometry and NMR
    • Screening Services
      • High Throughput Screening
      • Biochemical Assays
      • CRISPR-based gene editing
      • Cell-Based Assays
      • Human Pathogens Assays
      • Covid-19 -Virus Assays
      • Protein Lab
      • Agriculture Assays
      • Cosmetic Assays
    • Preclinical Development
    • Metabolomics Biomarkers
  • News
  • Join Us
  • Contact
  • EN
  • ES

Blog

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
Read more

First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species.

First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species.
Read more

BSP meeting Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research. March 8 – 11, Granada- Spain.

BSP meeting Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research. March 8 – 11, Granada- Spain.
Read more

Determination of a group of biomarkers through metabolomics studies that could be a “fingerprint” to diagnose metastatic colon cancer.

Determination of a group of biomarkers through metabolomics studies that could be a “fingerprint” to diagnose metastatic colon cancer.
Read more
  • First
  • Previous
  • 16
  • 17
  • 18
  • Next
  • Last